Platelet function and activation in Cavalier King Charles Spaniels with subclinical chronic valvular heart disease

Linda J. Tong College of Veterinary Medicine, Murdoch University, Murdoch, WA, Australia 6150.

Search for other papers by Linda J. Tong in
Current site
Google Scholar
PubMed
Close
 BVSC
,
Giselle L. Hosgood College of Veterinary Medicine, Murdoch University, Murdoch, WA, Australia 6150.

Search for other papers by Giselle L. Hosgood in
Current site
Google Scholar
PubMed
Close
 BVSC, PhD
,
Anne T. French Department of Small Animal Clinical Sciences, School of Veterinary Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland G61 1QH.

Search for other papers by Anne T. French in
Current site
Google Scholar
PubMed
Close
 MVB, PhD
,
Peter J. Irwin College of Veterinary Medicine, Murdoch University, Murdoch, WA, Australia 6150.

Search for other papers by Peter J. Irwin in
Current site
Google Scholar
PubMed
Close
 BVetMed, PhD
, and
Robert E. Shiel College of Veterinary Medicine, Murdoch University, Murdoch, WA, Australia 6150.

Search for other papers by Robert E. Shiel in
Current site
Google Scholar
PubMed
Close
 MVB, PhD

Abstract

OBJECTIVE To assess platelet closure time (CT), mean platelet component (MPC) concentration, and platelet component distribution width (PCDW) in dogs with subclinical chronic valvular heart disease.

ANIMALS 89 Cavalier King Charles Spaniels (CKCSs) and 39 control dogs (not CKCSs).

PROCEDURES Platelet count, MPC concentration, PCDW, and Hct were measured by use of a hematology analyzer, and CT was measured by use of a platelet function analyzer. Murmur grade and echocardiographic variables (mitral valve regurgitant jet size relative to left atrial area, left atrial-to-aortic diameter ratio, and left ventricular internal dimensions) were recorded. Associations between explanatory variables (sex, age, murmur grade, echocardiographic variables, platelet count, and Hct) and outcomes (CT, MPC concentration, and PCDW) were examined by use of multivariate regression models.

RESULTS A model with 5 variables best explained variation in CT (R2, 0.74), with > 60% of the variance of CT explained by mitral valve regurgitant jet size. The model of best fit to explain variation in MPC concentration included only platelet count (R2, 0.24). The model of best fit to explain variation in PCDW included platelet count and sex (R2, 0.25).

CONCLUSIONS AND CLINICAL RELEVANCE In this study, a significant effect of mitral valve regurgitant jet size on CT was consistent with platelet dysfunction. However, platelet activation, as assessed on the basis of the MPC concentration and PCDW, was not a feature of subclinical chronic valvular heart disease in CKCSs.

Abstract

OBJECTIVE To assess platelet closure time (CT), mean platelet component (MPC) concentration, and platelet component distribution width (PCDW) in dogs with subclinical chronic valvular heart disease.

ANIMALS 89 Cavalier King Charles Spaniels (CKCSs) and 39 control dogs (not CKCSs).

PROCEDURES Platelet count, MPC concentration, PCDW, and Hct were measured by use of a hematology analyzer, and CT was measured by use of a platelet function analyzer. Murmur grade and echocardiographic variables (mitral valve regurgitant jet size relative to left atrial area, left atrial-to-aortic diameter ratio, and left ventricular internal dimensions) were recorded. Associations between explanatory variables (sex, age, murmur grade, echocardiographic variables, platelet count, and Hct) and outcomes (CT, MPC concentration, and PCDW) were examined by use of multivariate regression models.

RESULTS A model with 5 variables best explained variation in CT (R2, 0.74), with > 60% of the variance of CT explained by mitral valve regurgitant jet size. The model of best fit to explain variation in MPC concentration included only platelet count (R2, 0.24). The model of best fit to explain variation in PCDW included platelet count and sex (R2, 0.25).

CONCLUSIONS AND CLINICAL RELEVANCE In this study, a significant effect of mitral valve regurgitant jet size on CT was consistent with platelet dysfunction. However, platelet activation, as assessed on the basis of the MPC concentration and PCDW, was not a feature of subclinical chronic valvular heart disease in CKCSs.

All Time Past Year Past 30 Days
Abstract Views 56 0 0
Full Text Views 808 655 20
PDF Downloads 210 127 7
Advertisement